Published on August 26, 2021
A Discussion on COVID-19 Immunity in Patients With CLL
One of the great difficulties of living with a blood cancer is being immunocompromised. Right now, COVID-19 immunity after vaccination is on the minds of many CLL survivors and their care partners. Follow along as Patient Power co-founder and care partner Esther Schorr and CLL patient advocate Michele Nadeem-Baker talk with CLL experts Alessandra Ferrajoli, MD, from the MD Anderson Cancer Center and Jacqueline Claudia Barrientos, MD, from the Feinstein Institutes for Medical Research at Northwell Health about this important topic.
Support for this series has been provided by AbbVie, Inc. and Genentech, Inc. Patient power maintains complete editorial control and is solely responsible for program content.